Jabil and United Natural Foods both climb following earnings reports Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- 9 Meters Biopharma (NMTR) up 19% after announcing final results from the Phase 2 study of vurolenatide and the outcome from its End-of-Phase 2 meeting with the FDA
- Lucid Group (LCID) up 4% after Cantor Fitzgerald initiated coverage of the stock with an Overweight rating and $23 price target
- Cogent Communications (CCOI) up 5% after KeyBanc upgraded shares to Overweight
- Merck (MRK) up 1% after announcing that Keytruda, Merck's anti-PD-1 therapy, received four new approvals from Japan's Ministry of Health, Labor and Welfare
UP AFTER EARNINGS -
- Jabil (JBL) up 4%
- United Natural Foods (UNFI) up 3%
DOWN AFTER EARNINGS -
LOWER -
- Avidity Biosciences (RNA) down 20% after reporting that that the FDA has placed a partial clinical hold on new participant enrollment in the Phase 1/2 MARINA clinical trial of AOC 1001 in adults with myotonic dystrophy type 1
- Avient (AVNT) down 2% after cutting its Q3 and FY22 guidance
Symbols:
NMTR MRK LCID CCOI UNFI JBL SNX AVNT RNA Keywords: Fly Intel, Wall Street, Top Stories, Stocks